Tag: cannabis

EMMAC Life Sciences partner with Hyris to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp.
June 24, 2019 Off

EMMAC Life Sciences partner with Hyris to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp.

By BusinessWire

EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.

FDA issues three warning letters to companies dealing with cannabis related products
April 2, 2019 Off

FDA issues three warning letters to companies dealing with cannabis related products

By Dino Mustafić

In a statement from the US FDA commissioner, the FDA on Tuesday said it has issued warning letters, in collaboration with the Federal Trade Commission, to three companies – Advanced Spine and Pain LLC (d/b/a Relievus), Nutra Pure LLC and PotNetwork Holdings Inc. – in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.

EMMAC Life Sciences Ltd: Medalchemy, EMMAC’s Spanish GMP Certified Laboratory, Secures Approval to Import Medical Cannabis for Scientific Research
March 19, 2019 Off

EMMAC Life Sciences Ltd: Medalchemy, EMMAC’s Spanish GMP Certified Laboratory, Secures Approval to Import Medical Cannabis for Scientific Research

By BusinessWire

EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical cannabis company, is pleased to announce that Medalchemy, EMMAC’s fully-licensed GMP certified laboratory in Alicante, Spain, has secured approval from the Spanish Health Authorities AEMPS to import medical cannabis for scientific research.

Canopy Growth Corporation, Beckley Canopy Therapeutics join as exclusive distributors of newly formed Spectrum UK’s cannabis medicinal products in UK
January 21, 2019 Off

Canopy Growth Corporation, Beckley Canopy Therapeutics join as exclusive distributors of newly formed Spectrum UK’s cannabis medicinal products in UK

By Dino Mustafić

The UK market focused joint venture between Canopy Growth Corporation and Beckley Canopy Therapeutics will exclusively distribute Cannabis medicinal products of newly formed, built-for-purpose distribution company that will introduce Spectrum Cannabis medicinal cannabis products to UK patients and doctors. 

Cannabis market use looks to rise
April 13, 2017 Off

Cannabis market use looks to rise

By Dino Mustafić

The legal cannabis market was worth an estimated $6.6 billion in 2016, and is projected to grow at a compound annual growth rate (CAGR) of 16% or reaching more than $24 billion by 2025.